LifeSeasons and Dr. Dale Bredesen Announce New Products to Support the Treatment of Alzheimer’s Disease and Cognitive Decline

LifeSeasons is proud to introduce ReCODE Protocol, a new line of cognitive support supplements formulated with world-renowned neurologist and author of the New York Times bestseller, The End of Alzheimer’s, Dale Bredesen, MD.

DALLAS, March 4, 2019 /PRNewswire/ -- LifeSeasons is proud to introduce ReCODE Protocol, a new line of cognitive support supplements formulated with world-renowned neurologist and author of the New York Times bestseller, The End of Alzheimer’s, Dale Bredesen, MD. The ReCODE Protocol features a core set of products expertly crafted to enhance a personalized, integrative treatment plan that has been shown to improve outcomes in those diagnosed with cognitive impairment and Alzheimer’s Disease.

Introducing ReCODE Protocol, a line of targeted nutrition supplements strategically formulated to support cognitive health based on the research of leading neurologist Dale Bredesen, MD.

The ReCODE Protocol core set consists of four products—Daily Multivitamin, Daily Omegas, Daily Probiotics and Daily Balance—that have been formulated to address the vitamin, mineral, and supplement needs of those seeking to support their cognitive health. Additional line items that address the six subtypes of Alzheimer’s Disease (inflammatory, glycotoxic, atrophic, toxic, vascular, and traumatic) will be available for individuals who undergo lab testing and receive a ReCODE Report via AHNP Precision Health.

Alzheimer’s Disease is a progressive, fatal disease of the brain that impairs daily functioning by gradually destroying memory, thinking, and problem-solving abilities. Biological changes in the brain are believed to start decades before cognitive impairment or clinical symptoms become apparent. Alzheimer’s Disease is the most common form of dementia—according to the World Health Organization, dementia affects 50 million people worldwide with 10 million new cases diagnosed each year.

“LifeSeasons is committed to improving the lives of millions, and we are humbled and excited to work hand-in-hand with Dr. Bredesen to develop these targeted supplements,” says Darrin Peterson, LifeSeasons Founder and CEO. “As the leader in supplements that address chronic disease, diabetes, cardiovascular concerns, and more, it’s a natural step for us to partner with Dr. Bredesen on his quest to improve brain function, eradicate Alzheimer’s, and relieve the burden of caring for cognitively impaired individuals for millions of families.”

LifeSeasons will debut the ReCODE Protocol core set and subtype-specific formulas at Natural Products Expo West in Anaheim, CA this week. A full launch in retail, direct-to-consumer, and practitioner channels is scheduled to follow.

About ReCODE Report
ReCODE Report is a comprehensive personalized program designed to improve cognition and reverse the cognitive decline of SCI, MCI, and early Alzheimer’s Disease. It is based on the Bredesen Protocol, a treatment protocol identified by neurology research pioneer and AHNP Precision Health Chief Science Officer and Board Member, Dr. Dale Bredesen, MD.

About LifeSeasons
LifeSeasons is an innovative health and wellness brand combining the power of nature with cutting-edge science. LifeSeasons manufactures synergistic, nutraceutical supplements, using clinically-tested, bio-available ingredients to create targeted, condition-specific formulas. LifeSeasons products are currently sold in premier, independent health retailers, Sprouts, Whole Foods Markets, The Vitamin Shoppe, and online.

For more information, please visit:

DaleBredesen.com
lifeseasons.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/lifeseasons-and-dr-dale-bredesen-announce-new-products-to-support-the-treatment-of-alzheimers-disease-and-cognitive-decline-300805488.html

SOURCE Lifeseasons, Inc.

MORE ON THIS TOPIC